Found 302 matching trials
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML) PHASE1 This open-label Phase I study is designed to determine the maximum tolerate...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Randomized Clinical Study Assessing Haplo vs. URD in AML NA This study compares haplo-identical family donor stem cell transplantation ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT PHASE1 The primary goal of thos study is to assess safety of Ultraviolet (UV) Phot...
Show More Location
Hadassah Medical Organization
Learn More & Join Trial
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL PHASE3 With this protocol the ALL-SCT BFM international study group wants
* to ev...
Show More Location
Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie
Learn More & Join Trial
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation PHASE1 The goal of this clinical research study is to learn if giving romidepsin b...
Show More Location
The Ohio State University Cancer Center
Learn More & Join Trial
Stem Cell Transplantation (SCT) for Genetic Diseases NA OBJECTIVES: I. Ascertain whether stem cell transplantation (SCT) is an effe...
Show More Location
University of California Los Angeles Medical Center
Learn More & Join Trial
Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL) PHASE2 The present study is a multicenter, prospective phase II-study investigatin...
Show More Location
University Medical Center Hamburg-Eppendorf
Learn More & Join Trial
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR NA This research study is for subjects that are receiving a bone marrow transp...
Show More Location
Texas Childen's Hospital
Learn More & Join Trial
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients PHASE4 Early reduction of immunosuppressive agents after HLA matched donor transpl...
Show More Location
Shanghai First People's HOSPITAL
Learn More & Join Trial
Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND) N/A Cytomegalovirus (CMV) infection is a common complication in patients underg...
Show More Location
Hospital Universitario Reina Sofía
Learn More & Join Trial